ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Merck Will Close Irish Drug Plant

by Alex Scott
March 18, 2013 | APPEARED IN VOLUME 91, ISSUE 11

Merck & Co. will close its active pharmaceutical ingredients manufacturing plant in Rathdrum, Ireland, by the end of 2015 with the loss of 280 jobs. The plant is being shut down to cut costs. Manufacturing at the plant, including the production of APIs for allergy drugs Claritin and Clarinex, will be relocated to the firm’s sites in Ballydine, Ireland, and Singapore. The pharmaceutical company will continue to employ about 2,000 people in Ireland even after the plant is closed or sold. The firm took over the Rathdrum plant in 2009 as part of its acquisition of rival Schering-Plough.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment